Your browser doesn't support javascript.
The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.
McNett, Molly; Fink, Ericka L; Schober, Michelle; Mainali, Shraddha; Helbok, Raimund; Robertson, Courtney L; Mejia-Mantilla, Jorge; Kurtz, Pedro; Righy, Cássia; Roa, Juan D; Villamizar-Rosales, Carlos; Altamirano, Valeria; Frontera, Jennifer A; Maldonado, Nelson; Menon, David; Suarez, Jose; Chou, Sherry H Y.
  • McNett M; College of Nursing, The Ohio State University, Columbus, OH, USA. mcnett.21@osu.edu.
  • Fink EL; Division of Pediatric Critical Care Medicine and Safar Center for Resuscitation Research, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Schober M; Primary Children's Hospital, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Mainali S; Division of Stroke and Neurocritical Care, Department of Neurology, The Ohio State University, Columbus, OH, USA.
  • Helbok R; Neurocritical Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Robertson CL; Departments of Anesthesiology and Critical Care Medicine, and Pediatrics, The Johns Hopkins University SOM, Johns Hopkins Children's Center, Baltimore, MD, USA.
  • Mejia-Mantilla J; Department of Neuro-Intensive Care and Anesthesiology, Fundacio Valle del Lili, University Hospital, Cali, Colombia.
  • Kurtz P; Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil.
  • Righy C; National Institute of Infectious Diseases Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
  • Roa JD; Department of Pediatric Neurology and Critical Care, Universidad Nacional de Colombia and Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia.
  • Villamizar-Rosales C; The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Altamirano V; The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Frontera JA; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA.
  • Maldonado N; Department of Neurology, Universidad San Francisco de Quito (USFQ), de los Valles Quito, Ecuador.
  • Menon D; Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital Cambridge, Cambridge, UK.
  • Suarez J; Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Chou SHY; Departments of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh School of Medicine, Safar Center for Resuscitation Research, Pittsburgh, PA, USA.
Neurocrit Care ; 33(3): 793-828, 2020 12.
Article Dans Anglais | MEDLINE | ID: covidwho-778078
ABSTRACT
Since its original report in January 2020, the coronavirus disease 2019 (COVID-19) due to Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection has rapidly become one of the deadliest global pandemics. Early reports indicate possible neurological manifestations associated with COVID-19, with symptoms ranging from mild to severe, highly variable prevalence rates, and uncertainty regarding causal or coincidental occurrence of symptoms. As neurological involvement of any systemic disease is frequently associated with adverse effects on morbidity and mortality, obtaining accurate and consistent global data on the extent to which COVID-19 may impact the nervous system is urgently needed. To address this need, investigators from the Neurocritical Care Society launched the Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID). The GCS-NeuroCOVID consortium rapidly implemented a Tier 1, pragmatic study to establish phenotypes and prevalence of neurological manifestations of COVID-19. A key component of this global collaboration is development and application of common data elements (CDEs) and definitions to facilitate rigorous and systematic data collection across resource settings. Integration of these elements is critical to reduce heterogeneity of data and allow for future high-quality meta-analyses. The GCS-NeuroCOVID consortium specifically designed these elements to be feasible for clinician investigators during a global pandemic when healthcare systems are likely overwhelmed and resources for research may be limited. Elements include pediatric components and translated versions to facilitate collaboration and data capture in Latin America, one of the epicenters of this global outbreak. In this manuscript, we share the specific data elements, definitions, and rationale for the adult and pediatric CDEs for Tier 1 of the GCS-NeuroCOVID consortium, as well as the translated versions adapted for use in Latin America. Global efforts are underway to further harmonize CDEs with other large consortia studying neurological and general aspects of COVID-19 infections. Ultimately, the GCS-NeuroCOVID consortium network provides a critical infrastructure to systematically capture data in current and future unanticipated disasters and disease outbreaks.
Sujets)
Mots clés

Texte intégral: Disponible Collection: Bases de données internationales Base de données: MEDLINE Sujet Principal: Éléments de données communs / Formulaires comme sujet / COVID-19 / Maladies du système nerveux Type d'étude: Rapport de cas / Étude observationnelle / Révision / Examen systématique/Méta-analyse Les sujets: Covid long Limites du sujet: Humains langue: Anglais Revue: Neurocrit Care Thème du journal: Neurologie / Soin critique Année: 2020 Type de document: Article Pays d'affiliation: S12028-020-01100-4

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Collection: Bases de données internationales Base de données: MEDLINE Sujet Principal: Éléments de données communs / Formulaires comme sujet / COVID-19 / Maladies du système nerveux Type d'étude: Rapport de cas / Étude observationnelle / Révision / Examen systématique/Méta-analyse Les sujets: Covid long Limites du sujet: Humains langue: Anglais Revue: Neurocrit Care Thème du journal: Neurologie / Soin critique Année: 2020 Type de document: Article Pays d'affiliation: S12028-020-01100-4